Relationships between HCV genotype and serological group in patients, except for genotype 1 or 2

Kanzo ◽

10.2957/kanzo.59.437 ◽

2018 ◽

Vol 59 (8) ◽

pp. 437-438

Author(s):

Mariko Kobayashi ◽

Norio Akuta ◽

Fumitaka Suzuki ◽

Hitomi Sezaki ◽

Yoshiyuki Suzuki ◽

...

Keyword(s):

Hcv Genotype ◽

Serological Group

Download Full-text

Thyroid dysfunction induced by peginterferon alfa-2b (Peg-2b)/Ribavirin (RBV) is a favorable predictor of SVR in difficult-to-treat patients with HCV Genotype 1 (G1) infection

Zeitschrift für Gastroenterologie ◽

10.1055/s-0032-1324001 ◽

2012 ◽

Vol 50 (08) ◽

Author(s):

S Mauss ◽

D Hueppe ◽

E Zehnter ◽

MP Manns ◽

G Teuber ◽

...

Keyword(s):

Thyroid Dysfunction ◽

Hcv Genotype ◽

Hcv Genotype 1 ◽

Peginterferon Alfa

Download Full-text

High virologic response rate at End of Treatment (EOT) following triple therapy of previously untreated HCV Genotype 1 (G1) infection with boceprevir in German real-life

Zeitschrift für Gastroenterologie ◽

10.1055/s-0034-1386302 ◽

2014 ◽

Vol 52 (08) ◽

Author(s):

P Buggisch ◽

H Löhr ◽

G Teuber ◽

H Steffens ◽

M Kraus ◽

...

Keyword(s):

Triple Therapy ◽

Response Rate ◽

Real Life ◽

Virologic Response ◽

Hcv Genotype ◽

End Of Treatment ◽

Hcv Genotype 1 ◽

Virologic Response Rate

Download Full-text

Baseline predictors of an early virologic response (EVR) in previously untreated patients undergoing boceprevir (BOC) triple therapy for HCV genotype 1 infection in German real-life

Zeitschrift für Gastroenterologie ◽

10.1055/s-0034-1397212 ◽

2015 ◽

Vol 53 (01) ◽

Author(s):

P Buggisch ◽

H Löhr ◽

G Teuber ◽

H Steffens ◽

M Kraus ◽

...

Keyword(s):

Triple Therapy ◽

Real Life ◽

Virologic Response ◽

Early Virologic Response ◽

Hcv Genotype ◽

Download Full-text

Baseline gamma-GT levels within the normal range predict high virologic response rates in treatment-naïve patients undergoing boceprevir triple therapy for HCV genotype 1 (G1) infection

Zeitschrift für Gastroenterologie ◽

10.1055/s-0034-1397211 ◽

2015 ◽

Vol 53 (01) ◽

Author(s):

P Buggisch ◽

HF Löhr ◽

G Teuber ◽

H Steffens ◽

MR Kraus ◽

...

Keyword(s):

Triple Therapy ◽

Response Rates ◽

Virologic Response ◽

Normal Range ◽

Hcv Genotype ◽

Treatment Naïve ◽

Download Full-text

Efficacy and safety of Boceprevir triple therapy in previously treated patients with HCV Genotype 1 (G1) infection in German real-life

Zeitschrift für Gastroenterologie ◽

10.1055/s-0035-1567991 ◽

2015 ◽

Vol 53 (12) ◽

Author(s):

P Buggisch ◽

H Löhr ◽

G Teuber ◽

H Steffens ◽

M Kraus ◽

...

Keyword(s):

Triple Therapy ◽

Real Life ◽

Efficacy And Safety ◽

Hcv Genotype ◽

Previously Treated Patients ◽

Previously Treated ◽

Download Full-text

Low frequency of drug-drug interactions (DDIs) with the novel all oral antivirals elbasvir (EBV) and grazoprevir (GRZ) in patients with HCV genotype 1 infection in German real-world

Zeitschrift für Gastroenterologie ◽

10.1055/s-0036-1587006 ◽

2016 ◽

Vol 54 (08) ◽

Author(s):

P Buggisch ◽

H Löhr ◽

G Teuber ◽

H Steffens ◽

M Kraus ◽

...

Keyword(s):

Drug Interactions ◽

Low Frequency ◽

The Novel ◽

Hcv Genotype ◽

Download Full-text

High real-world effectiveness of elbasvir/grazoprevir (EBR/GZR) in PWID on opioid substitution therapy with HCV genotype 1 (GT1) infection: results from the German Hepatitis C Registry (DHC-R)

10.1055/s-0039-1695339 ◽

2019 ◽

Author(s):

S Christensen ◽

A Stoehr ◽

M Cornberg ◽

H Klinker ◽

R Heyne ◽

...

Keyword(s):

Hepatitis C ◽

Substitution Therapy ◽

Opioid Substitution Therapy ◽

Hcv Genotype ◽

Hcv Genotype 1 ◽

Opioid Substitution

Download Full-text

Faculty Opinions recommendation of Boceprevir for untreated chronic HCV genotype 1 infection.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.13863968.15301070 ◽

2012 ◽

Author(s):

Jean-Michel Pawlotsky

Keyword(s):

Hcv Genotype ◽

Hcv Genotype 1 ◽

Download Full-text

Faculty Opinions recommendation of Meta-analysis: IL-28B genotype and sustained viral clearance in HCV genotype 1 patients.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717847853.793453175 ◽

2012 ◽

Author(s):

Guadalupe Garcia-Tsao

Keyword(s):

Meta Analysis ◽

Viral Clearance ◽

Hcv Genotype ◽

Download Full-text

Faculty Opinions recommendation of Sofosbuvir (GS-7977) plus peginterferon/ribavirin in treatment-naïve patients with HCV genotype 1: a randomized, 28-day, dose-ranging trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717969174.793469129 ◽

2013 ◽

Author(s):

Philip Rosenthal

Keyword(s):

Hcv Genotype ◽

Treatment Naïve ◽

Dose Ranging ◽

Download Full-text